Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 29, 2017

DrugPatentWatch Database Preview

Albuterol sulfate - Generic Drug Details

« Back to Dashboard

What are the generic sources for albuterol sulfate and what is the scope of albuterol sulfate patent protection?

Albuterol sulfate
is the generic ingredient in fifteen branded drugs marketed by Mova, 3M, Muro, Vintage, Copley Pharm, Glaxosmithkline, Pliva, Apotex Inc, Warner Chilcott, Teva, Ucb Inc, Roxane, Watson Labs, Dava Pharms Inc, Actavis Mid Atlantic, Teva Branded Pharm, Sun Pharm Inds, Ritedose Corp, Amneal Pharms, Hi Tech Pharma, Teva Pharms, Schering, Mylan Speciality Lp, Am Therap, Bausch And Lomb, Sandoz, Mylan Speclt, G And W Labs Inc, Nephron, Landela Pharm, Watson Labs Inc, Vistapharm, Mylan, Wockhardt Eu Operatn, Boehringer Ingelheim, Cipla Ltd, Watson Labs Teva, and Sandoz Inc, and is included in eighty-two NDAs. There are fifty-two patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Albuterol sulfate has three hundred and sixty-one patent family members in forty-two countries.

There are thirty-seven drug master file entries for albuterol sulfate. Forty-three suppliers are listed for this compound. There is one tentative approval for this compound.

Summary for Generic Name: albuterol sulfate

Drug Master File Entries: see list37
Suppliers / Packagers: see list43
Bulk Api Vendors: see list135
Clinical Trials: see list366
Therapeutic Class:Respiratory Tract Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:albuterol sulfate at DailyMed

Pharmacology for Ingredient: albuterol sulfate

Tentative approvals for ALBUTEROL SULFATE

Applicant Application No. Strength Dosage Form
► Subscribe► SubscribeEQ 0.083% BASE;0.017%SOLUTION;INHALATION
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Boehringer Ingelheim
albuterol sulfate; ipratropium bromide
SPRAY, METERED;INHALATION021747-001Oct 7, 2011RXYesYes7,396,341► SubscribeY ► Subscribe
albuterol sulfate
TABLET;ORAL072620-001Dec 5, 1989DISCNNoNo► Subscribe► Subscribe
albuterol sulfate
AEROSOL, METERED;INHALATION020983-001Apr 19, 2001BXRXYesYes6,431,168*PED► SubscribeY► Subscribe
albuterol sulfate
TABLET;ORAL072938-001Mar 30, 1990DISCNNoNo► Subscribe► Subscribe
Apotex Inc
albuterol sulfate
SOLUTION;INHALATION075717-001Feb 2, 2007DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Predict branded drug patent expiration
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus